Isolation of a Rickettsia slovaca-Like Agent from Dermacentor variabilis Ticks in Vero Cell Culture

Abstract

Rickettsia slovaca is transmitted by Dermacentor marginatus ticks, and is the causative agent of tick-borne lymphadenopathy and Dermacentor-borne necrosis erythema lymphadenopathy throughout Europe. It has not been found in New World ticks, nor have tick-borne lymphadenopathy or Dermacentor-borne necrosis erythema lymphadenopathy been reported in humans in the Americas. Here we describe the isolation of a R. slovaca-like agent from D. variabilis nymphs from a colony of ticks derived from field collected adults.

Introduction

Rickettsia slovaca is the causative agent of tick-borne lymphadenopathy and Dermacentor-borne necrosis erythema lymphadenopathy. It was first isolated from Dermacentor marginatus ticks in 1968 (Brezina et al. 1969), but wasn’t recognized as a human pathogen until 1997 (Raoult et al. 1997). Since then, it has been observed throughout Europe, with D. marginatus as the recognized tick vector (Marquez et al. 2006). Dermacentor spp. in the United States are known vectors of rickettsial agents, including Rickettsia rickettsii, R.montanensis, and R. phillipi (364D) (Ammerman et al. 2004). R. slovaca is, historically, a strictly European pathogen and as such has not been found in New World ticks nor been implicated as a cause of human disease in the United States.

Nymphs used in this study originated from a colony of D. variabilis established from adult ticks collected in North Carolina and Virginia. These ticks were obtained for the purpose of introducing fresh genetic material into our currently maintained laboratory colony. Upon receipt, the ticks were tested and found positive for rickettsial DNA. The origin of the infection in ticks is unknown, but sequence analysis showed 100% identity at six gene targets to the 1968 isolate of R. slovaca from D. marginatus in Slovakia (Gen- Bank accession no. CP003375.1, Zemtsova et al. 2016). Here we describe the first cell culture isolation of this rickettsial agent from Dermacentor variabilis ticks.

Materials and Methods

The infected D. variabilis were from a colony derived from wild ticks collected in southeastern Virginia and northeastern North Carolina and maintained in a laboratory for several generations before being sent to our lab. Ten infected nymphs were surface sterilized by immersion for 10 minutes each in 70% ethanol and 10% Clorox solution. They were then rinsed in sterile water and air dried on sterile filter paper. Ticks were triturated in 2mL modified Eagle’s medium and added to a T25 flask of confluent Vero E6 cells. An additional 3mL of media was added to the flask, consisting of modified Eagle’s medium supplemented with 10% fetal bovine serum, 4mM l-glutamine, nonessential amino acids, HEPES, sodium pyruvate, 100 U/mL penicillin, 100 U/mL streptomycin, and 0.25 µg/mL amphotericin B. Cells were maintained at 34°C in an incubator with 5% CO₂. After 24 hours, the inoculum was removed and 5mL of medium, without antibiotics and antimycotics, was added. Thereafter, media was refreshed once weekly. The culture was monitored for signs of infection by examining cells fixed to glass slides with absolute methanol and stained with acridine orange (Becton, Dickinson and Company, Sparks, MD). Slides were then viewed under a microscope fitted for fluorescent microscopy for identification of live, rod-shaped, Rickettsia-like organisms. For cryopreservation, cells from a T25 flask (~25% infected) were detached with glass beads, spun at 300 × g, resuspended in 3mL of sucrose phosphate glutamate solution (Bovarnick et al. 1950), supplemented with 0.005M MgCl₂·6H₂O and Renografin (13.6 mL/liter), aliquoted, and stored in liquid nitrogen.

DNA from the cell culture was extracted using the Qiagen DNEasy Blood and Tissue kit (Qiagen Inc., Valencia, CA) according to manufacturer’s protocols and eluted in 200 µL (final volume). Multiple locus sequence analysis of the cultured rickettsial agent was done for the 17 kDa gltA, ompB, ompA, rpoB, and sca4 genes. Sequences were performed according to the same protocols as, and compared with, those of Rickettsia detected in D. variabilis and characterized in our laboratory previously (Zemtsova et al. 2016). A BLAST search was used to identify homologous sequences. Tick species identification was carried out by sequencing 12S mitochondrial DNA (Beati and Keirans 2001).

Results and Discussion

Small rods consistent with Rickettsia-like organisms were observed in culture by acridine orange staining 10 days post inoculation. Primary cultures of the R. slovaca-like agent did not initially show signs of cytopathic effects, and the monolayer remained intact for 14 days post-inoculation. Only after the first passage did the cells show cytopathic effects, beginning on day 4 with complete destruction of the monolayer by day 9. Additionally, live rickettsia were successfully recovered from cultures that had been stored for one year in liquid nitrogen.

Sequences of the cell culture PCR products targeting the ompA, 17 kDa, gltA, ompB, sca4, and rpoB genes showed 100% identity to those obtained from colony D. variabilis (GenBank acc. nos. KR559552, KR559550, KR559551, KR559553, KR559554, and KR559549), as well as to a 1968 isolate of R. slovaca from Dermacentor marginatus ticks collected in Slovakia (GenBank acc. no. CP003375.1). Sequencing of the 12S mitochondrial ribosomalDNAconfirmed that the ticks used for isolation were in fact D. variabilis (100% identity to GenBank acc. no. S83088.1).

Here we report the first isolation of a Rickettsia sp. identical, at six gene targets, to the European pathogen, R. slovaca from North American D. variabilis ticks. As far as we know, these ticks were field collected in North Carolina and Virginia and subsequently used to supplement our uninfected colony for the prevention of inbreeding. The infection was detected during routine testing procedures of both tick colonies and animal hosts. The primary suspects were R. montanensis or R. rickettsii, both of which are known to occur in D. variabilis in that region. The identification and isolation of R. slovaca from these ticks was unexpected. The original source and the history of R. slovaca introduction into D. variabilis ticks remain unknown (despite our sincere and diligent efforts to elucidate these). We can only state, unequivocally, that neither our laboratory nor the external facility from which ticks were acquired ever worked with any R. slovaca isolates or known European vectors of this pathogen. Based on the available data, it would be premature to claim that R. slovaca is actually present in natural populations of D. variabilis. Yet, isolation of this agent in cell culture from nymphal D. variabilis, which were fed as larvae on laboratory guinea pigs, confirms that the American dog tick is capable of maintaining the live pathogen and transmitting it both transovarially and transstadially. Therefore, it is likely that in case of R. slovaca importation (whether past or future) to North America this pathogen may be maintained locally by D. variabilis. Vector and reservoir competency studies as well as increased testing of wild D. variabilis will help determine whether this is a pathogen of consequence to public health in the United States